BSX slides almost 4% as stock trades below key moving averages and technical signals stay negative

BSX slides almost 4% as stock trades below key moving averages and technical signals stay negative
Boston Scientific slides 3.95% today

Boston Scientific Corporation (BSX) dropped 3.95% as strong bearish momentum and sustained selling pressure drove the move lower. The decline is supported by the stock trading below all major moving averages and persistent negative technical signals.

BSX price prediction
24H 3.13%
$44.81
48H 3.11%
$44.8
7D 3.77%
$45.09
1M 2.39%
$44.49
3M -1.61%
$42.75
6M -35.58%
$27.99
12M -55.07%
$19.52
Current price: $43.45 -0.875 1.97%
Real-time Data 10:03
Daily range 41.90 Arrow from to Icon 44.37
Weekly range 39.72 Arrow from to Icon 44.37
Loading...

Highlights

  • Boston Scientific trades below major moving averages, signaling sustained bearish momentum across all time frames.
  • Bearish momentum is reinforced by negative MACD and ADX readings, while short-term oscillators show mixed signals.
  • Price hovers at $42.89 with resistance at $43.62, support at $42.29, and a high probability of further downside toward $40.58 in the near term.
Anton Kharitonov, expert at Traders Union, sees Boston Scientific's technical structure as deeply negative. He notes the stock lost all key support from moving averages and registers no supportive fundamental or sentiment-driven news to counter persistent selling. With active sell signals from MACD and ADX, and an RSI below 40, he considers short-term recovery unlikely. He highlights that isolated positive intraday flows are not enough to alter the trend. "Given the absence of positive news and dominant bearish momentum, I expect further downside pressure to persist for now."
Viktoras Karapetjanc, expert at Traders Union, remains constructive despite the ongoing downside. He emphasizes the sector offers longer-term prospects and notes that even with the current pullback, the broader market context supports eventual stabilization. The analyst sees potential for technical reversals if resistance levels at $43.5 are reclaimed. He believes new institutional flows could quickly reignite a bullish move. "Short-term hurdles present compelling setups — I see real opportunity if the price recovers above resistance bands."
Sholanke Dele, market strategist, is skeptical about near-term recovery for BSX. He highlights that the stock's break below major support sends a clear risk warning. The lack of any catalyst in the news flow further weighs on market confidence. "Until sentiment improves or news emerges, I remain cautious on further downside."

Downtrend confirmed as multi-timeframe technicals reinforce bearish setup

BSX is trading below the MA-20 ($44.86), MA-50 ($49.62), and MA-200 ($76.84), confirming that sellers are in control across all timeframes. The nearest support sits at $42.29, with resistance at $43.5, and the alignment of MA-50 under MA-200 highlights the ongoing bearish structure. Technical momentum remains negative: MACD and ADX both forecast a sell, RSI is signaling additional downside at 39.97, and Stochastic RSI is overbought at 86.74. The CCI is neutral, while Bull/Bear Power stands positive at 0.47, reflecting some intraday buying but without shifting the broader bearish tone.

Earlier, analysts noted that Boston Scientific was exhibiting persistent bearish signals, with technical indicators and price action suggesting continued downside pressure. The current decline further reinforces this view, and traders should monitor for a decisive move below $42.29, which could open the door to accelerated losses toward the next volatility floor.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.